Central adjudication of serious adverse events did not affect trial's safety results: Data from the Efficacy of Nitric Oxide in Stroke (ENOS) trial.

<h4>Background and purpose</h4>Central adjudication of serious adverse events (SAEs) can be undertaken in clinical trials, especially for open-label studies where outcome assessment may be at risk of bias. This study explored the effect of central adjudication of SAEs on the safety results of the Ef...

Disgrifiad llawn

Wedi'i Gadw mewn:

Manylion Llyfryddiaeth
Prif Awduron:	Peter J Godolphin, Alan A Montgomery, Lisa J Woodhouse, Daniel Bereczki, Eivind Berge, Rónán Collins, Exuperio Díez-Tejedor, John Gommans, Kennedy R Lees, Serefnur Ozturk, Stephen Phillips, Stuart Pocock, Kameshwar Prasad, Szabolcs Szatmari, Yongjun Wang, Philip M Bath, Nikola Sprigg, ENOS Investigators
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Public Library of Science (PLoS) 2018-01-01
Cyfres:	PLoS ONE
Mynediad Ar-lein:	https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0208142&type=printable
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Central adjudication of serious adverse events did not affect trial's safety results: Data from the Efficacy of Nitric Oxide in Stroke (ENOS) trial.

Eitemau Tebyg